Aytu BioPharma, Inc.AYTUNASDAQ
Loading
Interest expense on outstanding debt
3Y CAGR
-18.3%/yr
Annual compound
Percentile
P67
Within normal range
vs 3Y Ago
0.5x
Contraction
Streak
4 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $2.71M | -26.9% |
| 2025 | $3.70M | -22.7% |
| 2024 | $4.79M | -3.4% |
| 2023 | $4.96M | -96.6% |
| 2022 | $147.50M | - |
| 2021 | $0.00 | - |
| 2020 | $0.00 | - |
| 2019 | $0.00 | -100.0% |
| 2018 | $749423.00 | -70.4% |
| 2017 | $2.53M | - |